Centers for Medicare and Medicaid Services 2013 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the ``Pilot Program for Parallel Review of Medical Products.'' The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.